NSCLC In A Nutshell

Tazemetostat is withdrawn from the market due to a risk of secondary malignancies. RECITE asks if romiplostim improves platelet counts for patients on oxaliplatin-based regimens with thrombocytopenia. Spoiler - yes it does, but does that make a difference? Check out the Oncology ...  Show more

Lots of FDA approval updates to discuss from the past few weeks: -Zongertinib gets approved in 1st line setting for ERBB2 TKD mutated metastatic NSLCLC -Encorafenib approval with cetuximab + FOLFOX -Teclistamab + Daratumumab approved in 2nd line setting for r/r multiple myeloma - ...  Show more

What’s hotter than a fresh-off-the-press book in your hands? Knowing exactly what’s going to blow your mind before it even drops. This week, Mikayla, Reggie, and Kennedy spill the tea on their most anticipated reads of 2025. From jaw-dropping plot twists to characters we’re alrea ...  Show more

finally launching Huda Hotline

RM TEASES NEW BTS MUSIC IS COMING ALONG ‘REALLY WELL,’ SAYS ARMY HAS MUCH TO ‘LOOK FORWARD TO’. 

Today's installment is a repost of a mix from 10 years ago looking at the best of 2015